RETINA-AI has released an Android version of its mobile app for eye care providers, Fluid-Intelligence, which uses AI to detect macular oedema and subretinal fluid on OCT scans of the retina.

The eyecare provider uses the app to take a picture of an OCT. The captured image is then sent to the cloud where RETINA-AI's proprietary machine learning algorithm determines the diagnosis and generates a report in real time. The creators say the app is a useful screening tool for the most common retinal diseases such as diabetic macular oedema, exudative macular degeneration, retinal vein occlusion macular oedema, central serous chorioretinopathy, and macula-off retinal detachments.

RETINA-AI's founder, Dr Stephen Odaibo, says the development and release of the Android app solidifies the company's technological capability in the mobile health sector. "Earlier this year RETINA-AI broke ground by developing  and releasing the world's first mobile AI app for eye care providers. That was the iOS version. Now by adding the Android we have demonstrated full spectrum technological capability to develop and deliver mobile AI products in healthcare."

RETINA-AI is sponsoring the DATUM alpha study, a multicenter retrospective image analysis validation study of Fluid Intelligence. In DATUM (Diagnostic mobile Artificial intelligence Technology for detecting fluid Underneath and Inside the Macula) board-certified ophthalmologists who have fellowship training in retina, compare their assessment of OCTs to the assessment of the AI app. Initial results are in press and show a sensitivity of 90% and a specificity of 82.5%. The company says more studies will follow DATUM as RETINA-AI continues to develop and train AI algorithms and that it has multiple AI diagnostic healthcare software products in the pipeline.